Comparison of two alternative combinations of nucleosides in HIV-1 infected patients with viral suppression on 3TC [lamivudine]. Randomized, multicentre open trial.

Trial Profile

Comparison of two alternative combinations of nucleosides in HIV-1 infected patients with viral suppression on 3TC [lamivudine]. Randomized, multicentre open trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Sep 2012

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/abacavir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms BICOMBO
  • Most Recent Events

    • 28 Feb 2012 Results published in Antiviral Therapy.
    • 10 May 2011 Additional lead trial centre identified as reported by European Clinical Trials Database.
    • 10 May 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2005-000005-65).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top